Although identifying and targeting immuno-suppressive TAM subpopulations based on single markers, such as CD163 or Arg-1, has shown positive results [23,24,25], developing these approaches remains challenging due to their variation between species and tumor types [26,27,28]. The gene discussed is ARG1; the disease is neoplasm.